Merck’s Keytruda, Lilly’s Lartruvo available via CDF

5th July 2017 Uncategorised 0

Patients with certain forms of lung cancer or sarcoma have now gained access to two new treatment options on the NHS in England after Merck’s Keytruda and Eli Lilly’s Lartruvo were added to the Cancer Drugs Fund.

More: Merck’s Keytruda, Lilly’s Lartruvo available via CDF
Source: News